Search research articles
Contact Us
Filters
Showing results (261-270 of 286) with videos related to
Page
of 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2016
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
Lowell E Schnipper, Nancy E Davidson, Dana S Wollins, et al.
Journal of the National Cancer Institute
|
September 11, 2021
Meta-Analysis of Quality of Life in Cancer Patients Treated With Immune Checkpoint Inhibitors
Brian D Gonzalez, Sarah L Eisel, Kristina E Bowles, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 3, 2023
Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials
Paul L Nguyen, Huei-Chung Rebecca Huang, Daniel E Spratt, et al.
Journal of Medical Imaging (Bellingham, Wash.)
|
September 2, 2024
Predicting peritumoral glioblastoma infiltration and subsequent recurrence using deep-learning-based analysis of multi-parametric magnetic resonance imaging
Sunwoo Kwak, Hamed Akbari, Jose A Garcia, et al.
European Urology
|
December 14, 2017
Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy
Daniel E Spratt, Darlene L Y Dai, Robert B Den, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2015
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
Lowell E Schnipper, Nancy E Davidson, Dana S Wollins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2018
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy
R Jeffrey Karnes, Vidit Sharma, Voleak Choeurng, et al.
The Lancet. Oncology
|
October 15, 2018
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial
Mack Roach, Jennifer Moughan, Colleen A F Lawton, et al.
JCO Precision Oncology
|
September 19, 2025
Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS Registry
Stacy Loeb, Scott W Keith, Laura Gross, et al.
JAMA Oncology
|
March 28, 2020
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial
Ryan Phillips, William Yue Shi, Matthew Deek, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 286) with videos related to
Sort By:
Page
of 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2016
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
Lowell E Schnipper, Nancy E Davidson, Dana S Wollins, et al.
Journal of the National Cancer Institute
|
September 11, 2021
Meta-Analysis of Quality of Life in Cancer Patients Treated With Immune Checkpoint Inhibitors
Brian D Gonzalez, Sarah L Eisel, Kristina E Bowles, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 3, 2023
Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials
Paul L Nguyen, Huei-Chung Rebecca Huang, Daniel E Spratt, et al.
Journal of Medical Imaging (Bellingham, Wash.)
|
September 2, 2024
Predicting peritumoral glioblastoma infiltration and subsequent recurrence using deep-learning-based analysis of multi-parametric magnetic resonance imaging
Sunwoo Kwak, Hamed Akbari, Jose A Garcia, et al.
European Urology
|
December 14, 2017
Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy
Daniel E Spratt, Darlene L Y Dai, Robert B Den, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2015
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
Lowell E Schnipper, Nancy E Davidson, Dana S Wollins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2018
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy
R Jeffrey Karnes, Vidit Sharma, Voleak Choeurng, et al.
The Lancet. Oncology
|
October 15, 2018
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial
Mack Roach, Jennifer Moughan, Colleen A F Lawton, et al.
JCO Precision Oncology
|
September 19, 2025
Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS Registry
Stacy Loeb, Scott W Keith, Laura Gross, et al.
JAMA Oncology
|
March 28, 2020
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial
Ryan Phillips, William Yue Shi, Matthew Deek, et al.
Page
of 29